Sepsis cost-effectiveness of therapy: Difference between revisions

Jump to navigation Jump to search
No edit summary
m (Bot: Removing from Primary care)
 
(7 intermediate revisions by 6 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{| class="infobox" style="float: right;"
| style="vertical-align: middle; padding: 5px;" align=center | [[File:Siren.gif|30px|link=Sepsis resident survival guide]]
| style="vertical-align: middle; padding: 5px;" align=center | [[Sepsis resident survival guide|'''Resident'''<br>'''Survival'''<br>'''Guide''']]
|}
{{Sepsis}}
{{Sepsis}}
{{CMG}};  '''Associate Editor(s)-In-Chief:''' [[Priyamvada Singh|Priyamvada Singh, M.B.B.S.]] [mailto:psingh@perfuse.org]


Please help WikiDoc by adding content here.  It's easy!  Click  [[Help:How to Edit a Page|here]]  to learn about editing.
{{SK}} sepsis syndrome; septic shock; septicemia


==Cost-Effectiveness of Therapy<ref name="urlProducts - Data Briefs - Number 62 - June 2011">{{cite web |url=http://www.cdc.gov/nchs/data/databriefs/db62.htm |title=Products - Data Briefs - Number 62 - June 2011 |format= |work= |accessdate=2012-09-17}}</ref>==
*Total nationwide inpatient annual costs of treating those hospitalized for septicemia have been rising and were estimated to be $14.6 billion in 2008.
*Even with this expenditure, the death rate was high.
*Patients who do survive severe cases are more likely to have negative long-term effects on health and on cognitive and physical functioning.
==References==
==References==
{{Reflist|2}}
{{reflist|2}}
==Related Chapters==
 
* [[Meningococcemia]]
{{WH}}
*[[Anaphylactic shock]]
{{WS}}
*[[Cardiogenic shock]]
 
*[[Neurogenic shock]]
[[Category:Needs overview]]
*[[Sepsis]]
*[[Shock (medical)|Shock]]
*[[Septic shock]]
*[[Systemic inflammatory response syndrome]] (SIRS)
[[Category:Needs content]]
[[Category:Medical emergencies]]
[[Category:Intensive care medicine]]
[[Category:Intensive care medicine]]
[[Category:Causes of death]]
[[Category:Causes of death]]
[[Category:Infectious disease]]
[[Category:Emergency medicine]]
[[Category:Emergency medicine]]
[[Category:Disease]]
[[Category:Disease]]
[[Category:Overview complete]]
[[Category:Emergency mdicine]]
[[Category:Medical emergencies]]
[[Category:Up-To-Date]]
{{WikiDoc Help Menu}}
[[Category:Infectious disease]]
{{WikiDoc Sources}}

Latest revision as of 00:07, 30 July 2020

Resident
Survival
Guide

Sepsis Microchapters

Home

Patient Information (Adult)

Patient Information (Neonatal)

Overview

Pathophysiology

Causes

Differentiating Sepsis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Sepsis cost-effectiveness of therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Sepsis cost-effectiveness of therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Sepsis cost-effectiveness of therapy

CDC on Sepsis cost-effectiveness of therapy

Sepsis cost-effectiveness of therapy in the news

Blogs on Sepsis cost-effectiveness of therapy

Directions to Hospitals Treating Sepsis

Risk calculators and risk factors for Sepsis cost-effectiveness of therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.B.B.S. [2]

Synonyms and keywords: sepsis syndrome; septic shock; septicemia

Cost-Effectiveness of Therapy[1]

  • Total nationwide inpatient annual costs of treating those hospitalized for septicemia have been rising and were estimated to be $14.6 billion in 2008.
  • Even with this expenditure, the death rate was high.
  • Patients who do survive severe cases are more likely to have negative long-term effects on health and on cognitive and physical functioning.

References

  1. "Products - Data Briefs - Number 62 - June 2011". Retrieved 2012-09-17.

Template:WH Template:WS